Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-12-15 Sale | 2021-12-17 4:03 pm | VIVEVE MEDICAL INC. | VIVE | Basta Steven L Director | 28 | $1.41 | $39 | 25 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-02 Option Award | 2026-01-02 5:46 pm | N/A 2036-01-01 | Phathom Pharmaceuticals Inc. | PHAT | Basta Steven L President and CEO | 477,190 | $0 | 585,976 (Direct) | View |
| 2025-12-17 Option Award | 2025-12-19 5:45 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Basta Steven L President and CEO | 62,038 | $0 | 113,786 (Direct) | View |
| 2025-12-17 Tax Withholding | 2025-12-19 5:45 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Basta Steven L President and CEO | 31,502 | $15.36 | 113,786 (Direct) | View |
| 2025-12-12 Option Award | 2025-12-15 4:15 pm | N/A 2035-12-11 | VYNE Therapeutics Inc. | VYNE | Basta Steven L Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2025-11-28 Exercise | 2025-12-02 6:45 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Basta Steven L President and CEO | 90,000 | $0 | 263,250 (Direct) | View |
| 2025-11-28 Tax Withholding | 2025-12-02 6:45 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Basta Steven L President and CEO | 48,375 | $15.62 | 263,250 (Direct) | View |
| 2025-09-25 Tax Withholding | 2025-09-26 7:03 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Basta Steven L President and CEO | 48,375 | $11.66 | 311,625 (Direct) | View |
| 2025-09-25 Exercise | 2025-09-26 7:03 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Basta Steven L President and CEO | 90,000 | $0 | 311,625 (Direct) | View |
| 2025-04-03 Option Award | 2025-04-03 5:30 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Basta Steven L President and CEO | 1,445,000 | $0 | 1,445,000 (Direct) | View |
Ownership | 2025-04-03 5:29 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Basta Steven L President and CEO | 0 | $0 | 0 (Direct) | View |
| 2024-12-12 Option Award | 2024-12-13 4:15 pm | N/A 2034-12-11 | VYNE Therapeutics Inc. | VYNE | Basta Steven L Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 5:10 pm | N/A 2033-12-31 | VYNE Therapeutics Inc. | VYNE | Basta Steven L Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-12-13 Option Award | 2023-12-15 5:02 pm | N/A 2033-12-12 | VYNE Therapeutics Inc. | VYNE | Basta Steven L Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:04 pm | N/A N/A | VIVEVE MEDICAL INC. | VIVE | Basta Steven L Director | 72,000 | $0 | 72,000 (Direct) | View |
| 2022-08-10 Option Award | 2022-08-12 5:10 pm | N/A 2032-08-10 | VYNE Therapeutics Inc. | VYNE | Basta Steven L Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2022-01-04 Option Award | 2022-01-06 4:02 pm | N/A 2032-01-03 | VIVEVE MEDICAL INC. | VIVE | Basta Steven L Director | 48,000 | $0 | 48,000 (Direct) | View |
| 2021-07-19 Option Award | 2021-07-20 5:04 pm | N/A 2031-07-19 | VYNE Therapeutics Inc. | VYNE | Basta Steven L Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2021-06-23 Option Award | 2021-06-25 4:07 pm | N/A 2031-06-22 | VIVEVE MEDICAL INC. | VIVE | Basta Steven L Director | 116,200 | $0 | 116,200 (Direct) | View |
| 2021-01-20 Option Award | 2021-01-22 7:15 pm | N/A N/A | VIVEVE MEDICAL INC. | VIVE | Basta Steven L Director | 50,000 | $0 | 50,000 (Direct) | View |